Abstract
Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 602-603 |
| Number of pages | 2 |
| Journal | Journal of Gastroenterology and Hepatology (Australia) |
| Volume | 18 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2003 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Gastroenterology
- Hepatology
Cite this
Diarrhea associated with lansoprazole. / Mukherjee, Sandeep.
In: Journal of Gastroenterology and Hepatology (Australia), Vol. 18, No. 5, 01.05.2003, p. 602-603.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Diarrhea associated with lansoprazole
AU - Mukherjee, Sandeep
PY - 2003/5/1
Y1 - 2003/5/1
N2 - Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.
AB - Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease. According to the manufacturer's package insert (TAP Pharmaceuticals, Lake Forest, IL, USA), the most common side-effects are diarrhea, headache and abdominal pain, which occur in approximately 3% of patients and are reversible with drug discontinuation. An unusual case of microscopic colitis is reported in a previously asymptomatic patient who developed new-onset diarrhea after initiation of lansoprazole. The case is reviewed and possible mechanisms of diarrhea secondary to proton pump inhibitors are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0038392681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038392681&partnerID=8YFLogxK
U2 - 10.1046/j.1440-1746.2003.02801.x
DO - 10.1046/j.1440-1746.2003.02801.x
M3 - Article
C2 - 12702056
AN - SCOPUS:0038392681
VL - 18
SP - 602
EP - 603
JO - Journal of Gastroenterology and Hepatology (Australia)
JF - Journal of Gastroenterology and Hepatology (Australia)
SN - 0815-9319
IS - 5
ER -